MabRella Study: A Study to Evaluate the Safety of Switching From Intravenous to Subcutaneous Administration of Rituximab During First-Line Treatment for Lymphoma
Clinical trial NCT01987505 · COMPLETED
Trial details
- NCT number
- NCT01987505
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-11
- Primary completion
- 2017-04-11
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.